Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6932186

N#Cc1ccc(NC(=O)c2cc(CNCc3ccncc3)on2)c(C(=O)O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 2/20 0.37
SORT1 Q99523 1/20 0.37
GSK3B P49841 2/20 0.36
NAMPT P43490 3/20 0.36
PPARG P37231 1/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
GPR6 P46095 1/20 0.35
ALDH1A1 P00352 2/20 0.34
SCN9A Q15858 1/20 0.34
CDK2 P24941 1/20 0.34
GSK3A P49840 1/20 0.34
STING1 Q86WV6 1/20 0.33
PYGL P06737 1/20 0.33
PYGM P11217 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16143633 0.95 ALB (0.40) ALBGSK3BNAMPTPPARGRAB9A
SCHEMBL6932202 0.87 MAPK1 (0.35) GSK3BNAMPTPPARGRAB9ANPC1
SCHEMBL6834689 0.87 SMN1; SMN2 (0.43) ALBRAB9ANPC1ALDH1A1CDK2
SCHEMBL6821753 0.78 ALB (0.41) ALBGSK3BPPARGRAB9ANPC1
SCHEMBL6822132 0.78 ALB (0.45) ALBRAB9ANPC1GPR6ALDH1A1
SCHEMBL6835713 0.78 ALB (0.45) ALBRAB9ANPC1GPR6ALDH1A1
SCHEMBL6835611 0.76 ALB (0.41) ALBRAB9ANPC1GPR6ALDH1A1
SCHEMBL6833211 0.74 SMN1; SMN2 (0.46) ALBRAB9ANPC1ALDH1A1CDK2
SCHEMBL6833758 0.73 SMN1; SMN2 (0.41) ALBRAB9ANPC1GPR6ALDH1A1
SCHEMBL6833592 0.72 ALB (0.41) ALBRAB9ANPC1GPR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALB 1417/4885SORT1 2421/4885GSK3B 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.